TB-500 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-11-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
Ropinirole, sold under the brand name Requip among others, is a medication used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). It is taken by mouth. Common side effects include sleepiness, vomiting, and dizziness. Serious side effects may include pathological gambling, hypersexuality, low blood pressure with standing and hallucinations. Use in pregnancy and breastfeeding is of unclear safety. It is a dopamine agonist and works by triggering dopamine D2 receptors. It was approved for medical use in the United States in 1997. It is available as a generic medication. In 2023, it was the 212th most commonly prescribed medication in the United States, with more than 2 million prescriptions.
=== 1948 === January 5: Burma (today Myanmar) becomes independent from the UK through the Burma Independence Act 1947. January 30: Mahatma Gandhi was assassinated. February 25: The Communist Party takes control of Czechoslovakia in the Czechoslovak coup d'état of 1948. March 5: The Berlin Crisis intensifies, according to General Lucius D. Clay March 10: Czechoslovak Foreign Minister Jan Masaryk is reported having committed suicide. March 12: The Costa Rican Civil War begins. March 17: The Treaty of Brussels, an agreement is signed by Britain, France, Belgium, the Netherlands, and Luxembourg, creating a collective defense alliance. (It was the precursor to NATO) April 3: Truman signs the Marshall Plan into effect. By the end of the programs, the United States has given $12.4 billion in economic assistance to Western European countries. April 9: La Violencia begins in Colombia between the Colombian Conservative Party and the Colombian Liberal Party. May 10: A parliamentary vote in southern Korea sees the confirmation of Syngman Rhee as President of the Republic of Korea, after a left-wing boycott. May 14: David Ben-Gurion declares Israeli independence from the United Kingdom. May 15: The British Mandate for Palestine is terminated, and any and all British authority in Palestine ends. As a result, the armies of the Kingdom of Egypt, Transjordan, the Kingdom of Iraq, Syria, Lebanon, Saudi Arabia, and the Kingdom of Yemen entered the former mandate to create an Arab state in Palestine in the place of the State of Israel.
By preventing black from the ability to attain mortgage loans from local banks, the New Deal private-public partnerships used redlining to protect the property values and investment opportunities for white middle-class homes. Therefore, redlining circumscribed black homeownership in middle-class neighborhoods through the spatial and social isolation of black Detroiters in Detroit's expanding ghettos. Simultaneously, this residential segregation also exacerbated the economic instability of black Detroiters as these residents were forced to succumb to deteriorating housing without appreciating assets while the high rates of unemployment of black Detroiters made them exceedingly vulnerable to losing their homes through eviction or tax foreclosure. Because the local government had the final say over the distribution of federal funds for home loan eligibility, there were no major alternatives for obtaining loans for a new home, which further promoted the precarious and unstable living conditions of black Detroiters. The redemptive capacity of the private-public partnership between local Detroit banks and the FHA-HOLC funneled a vicious territorialism of the white middle class that upheld the high property values of white neighborhoods by unequivocally suppressing the upward mobility of black Detroiters. Collectively, black integration into white neighborhoods greatly depreciated property values, further motivating white Detroiters to keep their neighborhoods segregated.
Sources: en.wikipedia.org
In 2019, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) recommended that product labels for all SSRIs and SNRIs, including sertraline, be updated to state that sexual dysfunction may be long-lasting even after treatment is stopped. Health Canada followed with similar label updates in 2021. In 2024, Australia's Therapeutic Goods Administration aligned all SSRI and SNRI product information to reflect this risk, noting that sertraline already carried a warning about persistent sexual dysfunction.
Joseph Robinette Biden Jr. was born on November 20, 1942, at St. Mary's Hospital in Scranton, Pennsylvania, to Catherine Eugenia "Jean" Biden (née Finnegan) and Joseph Robinette Biden Sr. He is the oldest child in a Catholic family of predominantly Irish descent. Biden has a sister, Valerie, and two brothers, James and Francis. Joseph Sr. had been wealthy, and the family purchased a home in the affluent Long Island suburb of Garden City, New York, in 1946. After he suffered business setbacks around the time Biden was seven years old, the family lived with Jean's parents in Scranton for several years. Scranton fell into economic decline during the 1950s, and Joseph Sr. could not find steady work. Beginning in 1953, when Biden was ten, the family lived in an apartment in Claymont, Delaware, before moving to a house in nearby Mayfield, Delaware. Joseph Sr. later became a successful used-car salesman, maintaining the family in a middle-class lifestyle. Growing up, Biden observed alcoholism in his family, deciding at a young age to be teetotal. At Archmere Academy in Claymont, Biden played baseball and was a standout halfback and wide receiver on the high school football team. Though a poor student, he was class president in his junior and senior years. He graduated in 1961. At the University of Delaware in Newark, Biden briefly played freshman football and received a Bachelor of Arts degree with a double major in history and political science in 1965. To overcome a childhood stutter, he memorized lines from Ralph Waldo Emerson and William Butler Yeats.
Since the onset of the 21st century, Australia has found that childhood obesity has followed trend with the United States. Information garnered has concluded that the increase has occurred in lower socioeconomic areas, where poor nutritional education has been blamed.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.